Loading...

Liquidia Corporation

LQDANASDAQ
Healthcare
Biotechnology
$24.10
$0.00(0.00%)

Liquidia Corporation (LQDA) Company Profile & Overview

Explore Liquidia Corporation’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Liquidia Corporation (LQDA) Company Profile & Overview

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

SectorHealthcare
IndustryBiotechnology
CEORoger A. Jeffs

Contact Information

919 328 4400
419 Davis Drive, Morrisville, NC, 27560

Company Facts

170 Employees
IPO DateJul 26, 2018
CountryUS
Actively Trading

Frequently Asked Questions

;